NYSE: NOVNov Inc Stock
$20.58+0.17 (+0.83%)
Updated Sep 20, 2023
NOV Price
$20.58
Fair Value Price
N/A
Market Cap
$8.10B
52 Week Low
$14.05
52 Week High
$24.83
P/E
19.42x
P/B
1.49x
P/S
0.79x
PEG
0.98x
Dividend Yield
0.97%
Revenue
$8.02B
Earnings
$417.00M
Gross Margin
20.9%
Operating Margin
7.6%
Profit Margin
5.2%
Debt to Equity
0.91
Operating Cash Flow
-$226M
Beta
1.31
Next Earnings
Oct 26, 2023
Ex-Dividend
Sep 14, 2023
Next Dividend
Sep 29, 2023
NOV Overview
NOV Inc. manufactures products for the oil and gas, industrial, and renewable energy sectors in the U.S. and internationally. Offerings include solids control and waste management equipment and services, portable power generation products, drill and wired pipes, drilling optimization and automation services, tubular inspection, repair, and coating services, instrumentation, measuring and monitoring services, downhole and fishing tools, and drill bits. NOV was founded in 1862 and is headquartered in Houston, TX.
Zen Score
–
Industry Average (34)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NOV scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NOV ($20.58) is trading above its intrinsic value of $11.86, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NOV is poor value based on its earnings relative to its share price (19.42x), compared to the US market average (14.54x)
P/E vs Market Valuation
NOV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NOV due diligence checks available for Premium users.
Be the first to know about important NOV news, forecast changes, insider trades & much more!
NOV News
Valuation
NOV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
19.42x
Industry
-4.16x
Market
14.54x
NOV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NOV is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
NOV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.49x
Industry
3.18x
NOV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NOV price to earnings growth (PEG)
For valuing profitable companies with growth potential
NOV is good value based... subscribe to Premium to read more.
PEG Value Valuation
NOV's financial health
Profit margin
Revenue
$2.1B
Net Income
$155.0M
Profit Margin
7.4%
NOV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NOV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$10.4B
Liabilities
$4.9B
Debt to equity
0.91
NOV's short-term assets ($5.61B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NOV's short-term assets ($5.61B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NOV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NOV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$72.0M
Investing
-$76.0M
Financing
-$32.0M
NOV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
NOV vs Oil & Gas Equipment & Service Stocks
Nov Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.